INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
15/07/2026
Voltar para busca
Dado oficial do USPTO
ENTEROME
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ENTEROME
ST13
US500000079126292Classe
1, 3, 5, 42
Pedido
79126292
Registro
4561761
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
43
Atualização mais recente
15/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 3, 5, 42
Data de depósito
03/01/2013
Data de registro
08/07/2014
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
22/04/2025
Última transação
15/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
PARIS, FR
Examinador
TANNER, MICHAEL R
Localização atual
Historical data usage
Titulares e representantes
Titulares
ENTEROME
Representantes
THOMAS M. PALISI Lerner David LLP
Classificação técnica
Classes Nice
Classe 1Classe 3Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical and biochemical substances used for the manufacture and preservation of foodstuffsof pharmaceuticalcosmetic and veterinary productsprobiotic bacteria and probiotic bacterial cultures for use in the manufacture of food products and pharmaceutical preparationsprebiotic bacteria and prebiotic bacterial cultures for use in the manufacture of food products and pharmaceutical preparationsenzymes for use in the manufacture of food products and pharmaceutical preparations
Classe 3
Cosmetic productscosmetic creams
Classe 5
Pharmaceutical and medicinal products for human and veterinary usepharmaceutical preparations for treating metabolic disordersimmunological disorderscancerscentral nervous systems disordersgastroenterological disordersinfectious diseasesdiarrheaconstipation and irritable bowel syndrome; veterinary productsanti-infective products for veterinary useveterinary pharmaceutical preparations for treatment of metabolic disordersimmunological disorderscancerscentral nervous systems disordersgastroenterological disordersinfectious diseases and diarrhea; medicinal products for human and veterinary usenutritional supplements containing probiotic compositions; sanitary products for use in medicinesanitary sterilizing preparationsdisinfectants for sanitary purposessanitary preparations for medical use; dietetic food and substances for medical use in the nature of meal replacement products and prepackaged meal plansnutritional meal replacement bars adapted for medical use for treating metabolic disordersimmunological disorderscentral nervous systems disordersgastroenterological disordersinfectious diseasesdiarrheaconstipation and irritable bowel syndromepreparedprepackaged entrees for medical use for treating metabolic disordersimmunological disorderscentral nervous systems disordersgastroenterological disordersinfectious diseasesdiarrheaconstipation and irritable bowel syndromepreparedprepackaged snack foods for medical use for treating metabolic disordersimmunological disorderscentral nervous systems disordersgastroenterological disordersinfectious diseasesdiarrheaconstipation and irritable bowel syndromepreparedprepackaged yogurts for medical use for treating metabolic disordersimmunological disorderscentral nervous systems disordersgastroenterological disordersinfectious diseasesdiarrheaconstipation and irritable bowel syndromepreparedprepackaged desserts for medical use for treating metabolic disordersimmunological disorderscentral nervous systems disordersgastroenterological disordersinfectious diseasesdiarrheaconstipation and irritable bowel syndrome; nutritional supplements for medical use; food additives for medical usedietary fiber for treating metabolic disordersgastroenterological disordersdiarrheaconstipation and irritable bowel syndrome; nutritional food additives for medical purposes in the nature of natural food extracts derived from fishmeatvegetablesmicroorganisms and crops
Classe 42
Human pharmaceutical research; research services provided by a pharmaceutical laboratoryproviding medical research testing services in the field of metabolic disordersimmunological disorderscentral nervous systems disordersgastroenterological disordersinfectious diseasesdiarrheaconstipationirritable bowel syndrome; Providing medical and scientific research information in the field of metabolic disordersimmunological disorderscentral nervous systems disordersgastroenterological disordersinfectious diseasesdiarrheaconstipationirritable bowel syndrome; providing medical and scientific research information in the field of pharmaceutical and clinical trials; scientific laboratory servicesgenetic testing of laboratory animals for pharmaceutical research purposes; biological research in the fields of microbiology and chemistry
Publicações
Histórico de despachos e eventos da marca no USPTO.
43 publicações encontradas
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
22/12/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
22/04/2025
71AG
REGISTERED-SEC.71 ACCEPTED
22/04/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
21/04/2025
ES71
TEAS SECTION 71 RECEIVED
09/12/2024
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
08/07/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
26/01/2023
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
12/12/2021
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
04/11/2021
INPC
INVALIDATION PROCESSED
04/11/2021
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
10/10/2021
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
10/02/2021
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
10/02/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/02/2021
ES75
TEAS SECTION 71 & 15 RECEIVED
29/12/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
23/01/2015
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/12/2014
FIMP
FINAL DISPOSITION PROCESSED
04/12/2014
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/10/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
08/07/2014
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
30/05/2014
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
12/02/2014
PUBO
PUBLISHED FOR OPPOSITION
14/01/2014
GPNX
NOTIFICATION PROCESSED BY IB
11/01/2014
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
25/12/2013
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
25/12/2013
NPUB
NOTICE OF PUBLICATION
25/12/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/12/2013
ALIE
ASSIGNED TO LIE
02/12/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/11/2013
CNEA
EXAMINERS AMENDMENT MAILED
22/10/2013
XAEC
EXAMINER'S AMENDMENT ENTERED
22/10/2013
CNEA
EXAMINERS AMENDMENT -WRITTEN
22/10/2013
RFNP
REFUSAL PROCESSED BY IB
15/05/2013
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
22/04/2013
RFRR
REFUSAL PROCESSED BY MPU
22/04/2013
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
20/04/2013
CNRT
NON-FINAL ACTION WRITTEN
19/04/2013
DOCK
ASSIGNED TO EXAMINER
17/04/2013
MAFR
APPLICATION FILING RECEIPT MAILED
15/03/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/03/2013
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/03/2013
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ENTEROME ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.